Editorial criticizes cost-benefit analysis that is among important criteria for proposed Food and Drug Administration rule to regulate electronic cigarettes, cigars and other tobacco products; calls analysis, which takes into account loss of pleasure smokers experience when they quit smoking, misguided if not absurd, and calls for approach to be abandoned before issuing final rule.